{
  "url": "https://openlegislation.uk/eu-regulation-2014-1228/annex-II",
  "json_url": "https://openlegislation.uk/eu-regulation-2014-1228/annex-II.json",
  "legislation": "eur/2014/1228",
  "legislation_title": "Commission Regulation (EU) No 1228/2014 of 17 November 2014 authorising and refusing to authorise certain health claims made on foods and referring to the reduction of disease risk (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2014-1228",
  "path": "annex/II",
  "kind": "annex",
  "number": "II",
  "heading": "Rejected health claims",
  "text": "Application — Relevant provisions of Regulation (EC) No 1924/2006\nNutrient, substance, food or food category\nClaim\nEFSA opinion reference\nArticle 14(1)(a) health claim referring to a reduction of a disease risk\nGlucosamine hydrocloride\nSlowing down/reduce the destruction process of cartilage of the musculoskeletal system and consequently reduce the risk of osteoarthritis.\nQ-2009-00412\nArticle 14(1)(a) health claim referring to a reduction of a disease risk\nIsolated soy protein\nProtein-rich soybean component has been shown to lower/reduce blood cholesterol; blood cholesterol lowering may reduce the risk of (coronary) heart disease.\nQ-2011-00784\nArticle 14(1)(a) health claim referring to a reduction of a disease risk\nPlant sterols in combination with Cholesternorm®mix\nActively lowers cholesterol.\nQ-2009-00237\nQ-2011-01114\nArticle 14(1)(a) health claim referring to a reduction of a disease risk\nEicosapentanoic acid (EPA)\nEPA has been shown to reduce the AA/EPA ratio in blood. A high AA/EPA level is a risk factor in the development of attention difficulties in children with ADHD-like symptoms. These children are also characterised by less hyperactivity and/or coexisting oppositional behaviour.\nQ-2012-00573\nArticle 14(1)(a) health claim referring to a reduction of a disease risk\nPlant stanols (as plant stanol esters)\nConsuming 2 g/day plant stanols (as plant stanol esters) as part of a diet low in saturated fat results in a 2-fold greater reduction in LDL-cholesterol than consuming a low saturated fat diet alone. High cholesterol is a risk factor in the development of coronary heart disease.\nQ-2012-00915",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2014/1228/annex/II",
    "retrieved_at": "2026-11-01T14:47:09.082712+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}